ZA966048B - Piperazine derivatives. - Google Patents

Piperazine derivatives.

Info

Publication number
ZA966048B
ZA966048B ZA9606048A ZA966048A ZA966048B ZA 966048 B ZA966048 B ZA 966048B ZA 9606048 A ZA9606048 A ZA 9606048A ZA 966048 A ZA966048 A ZA 966048A ZA 966048 B ZA966048 B ZA 966048B
Authority
ZA
South Africa
Prior art keywords
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
ZA9606048A
Other languages
English (en)
Inventor
Michael Gerard Kelly
Howard Langham Mansell
Andrew Fensome
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ZA966048B publication Critical patent/ZA966048B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9606048A 1995-07-20 1996-07-16 Piperazine derivatives. ZA966048B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9514901.9A GB9514901D0 (en) 1995-07-20 1995-07-20 Piperazine derivatives

Publications (1)

Publication Number Publication Date
ZA966048B true ZA966048B (en) 1998-01-16

Family

ID=10778004

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606048A ZA966048B (en) 1995-07-20 1996-07-16 Piperazine derivatives.

Country Status (21)

Country Link
EP (1) EP0839146B1 (xx)
JP (1) JP4166824B2 (xx)
KR (1) KR100447002B1 (xx)
CN (2) CN1077889C (xx)
AR (1) AR003451A1 (xx)
AT (1) ATE196294T1 (xx)
AU (1) AU700546B2 (xx)
BR (1) BR9609694A (xx)
CA (1) CA2227386C (xx)
DE (1) DE69610316T2 (xx)
DK (1) DK0839146T3 (xx)
ES (1) ES2150684T3 (xx)
GB (1) GB9514901D0 (xx)
GR (1) GR3034408T3 (xx)
HU (1) HUP9802447A3 (xx)
IL (1) IL122981A (xx)
MX (1) MX9800483A (xx)
NZ (1) NZ313231A (xx)
PT (1) PT839146E (xx)
WO (1) WO1997003982A1 (xx)
ZA (1) ZA966048B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US6469007B2 (en) * 2000-11-28 2002-10-22 Wyeth Serotonergic agents
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
KR20040105765A (ko) * 2002-03-12 2004-12-16 와이어쓰 키랄 ｎ-아릴 피페라진의 합성방법
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
JP2005527530A (ja) 2002-03-12 2005-09-15 ワイス キラル１，４−二置換ピペラジン
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
US6784294B2 (en) * 2002-03-12 2004-08-31 Wyeth Preparation of N1-(2′-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
PA8626301A1 (es) * 2004-03-19 2006-12-07 Wyeth Wyeth Proceso para preparar derivados de n-aril-piperazina
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
JP2008543867A (ja) 2005-06-17 2008-12-04 ワイス セロトニン阻害剤ならびに５−ｈｔ１ａアゴニストおよびアンタゴニストとして有用な三環系化合物
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
JPH10504275A (ja) * 1994-06-03 1998-04-28 ジョン・ワイス・アンド・ブラザー・リミテッド ピペラジン誘導体を製造するための新規な方法および中間体

Also Published As

Publication number Publication date
JP4166824B2 (ja) 2008-10-15
NZ313231A (en) 2001-03-30
DE69610316T2 (de) 2001-03-29
KR19990029067A (ko) 1999-04-15
EP0839146B1 (en) 2000-09-13
WO1997003982A1 (en) 1997-02-06
IL122981A0 (en) 1998-08-16
BR9609694A (pt) 1999-03-23
HUP9802447A2 (hu) 1999-08-30
GR3034408T3 (en) 2000-12-29
ES2150684T3 (es) 2000-12-01
AU6524996A (en) 1997-02-18
CN1309127A (zh) 2001-08-22
KR100447002B1 (ko) 2004-12-04
CA2227386A1 (en) 1997-02-06
CN1077889C (zh) 2002-01-16
HUP9802447A3 (en) 1999-11-29
AU700546B2 (en) 1999-01-07
MX9800483A (es) 1998-04-30
PT839146E (pt) 2000-12-29
DK0839146T3 (da) 2000-11-20
IL122981A (en) 2001-01-28
CA2227386C (en) 2006-05-16
DE69610316D1 (de) 2000-10-19
GB9514901D0 (en) 1995-09-20
EP0839146A1 (en) 1998-05-06
AR003451A1 (es) 1998-08-05
JPH11509544A (ja) 1999-08-24
CN1131861C (zh) 2003-12-24
ATE196294T1 (de) 2000-09-15
CN1190968A (zh) 1998-08-19

Similar Documents

Publication Publication Date Title
ZA964101B (en) Piperazine derivatives
ZA961444B (en) Pyrazolylbenzoyl derivatives.
IL117866A0 (en) Substituted piperazine derivatives
EG25227A (en) Heterocyclic compounds.
ZA978194B (en) Piperazine derivatives
ZA965935B (en) Heterocyclic compounds.
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
ZA962522B (en) Quinazoline derivatives.
PH30897A (en) 1-5 Benzodiazepine derivatives.
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA986390B (en) Piperazine derivatives
ZA961449B (en) Isoxazolylbenzoyl derivatives.
ZA985255B (en) Piperazine derivatives
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA966048B (en) Piperazine derivatives.
ZA941137B (en) Substitutet azolone derivatives.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
GB9509474D0 (en) Piperazine derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA982436B (en) Thiazolimine derivatives.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
GB9510600D0 (en) Piperazine derivatives
ZA956578B (en) Saccharin derivatives.